VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CRL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CRLCharles River Laboratories International, Inc.
$225.57$10.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCRLQuarterly Financials

Charles River Laboratories International, Inc. (CRL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Charles River Laboratories International, Inc. (CRL) quarterly income statement — complete revenue, gross profit & net income history

CRL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue995.83M994.23M1B1.03B984.17M1B1.01B1.03B1.01B1.01B1.03B1.06B1.03B1.1B989.16M973.13M913.93M905.05M895.94M914.61M
Revenue Growth %1.19%-0.83%-0.49%0.59%-2.71%-1.08%-1.64%-3.19%-1.73%-7.85%3.79%8.92%12.63%21.52%10.4%6.4%10.84%14.42%20.54%33.99%
Cost of Goods Sold716.51M686.37M666.06M675.07M666.44M718.3M660.74M672.4M666.72M649.39M664.78M660.96M651.72M700.96M618.93M616.4M577.11M557.94M558.71M572.59M
COGS % of Revenue71.95%69.04%66.28%65.41%67.72%71.65%65.44%65.53%65.91%64.08%64.75%62.36%63.31%63.73%62.57%63.34%63.15%61.65%62.36%62.6%
Gross Profit279.32M307.86M338.79M357.07M317.73M284.24M349.02M353.71M344.84M364.08M361.84M398.98M377.65M398.88M370.22M356.73M336.82M347.11M337.23M342.02M
Gross Margin %28.05%30.96%33.72%34.59%32.28%28.35%34.56%34.47%34.09%35.92%35.25%37.64%36.69%36.27%37.43%36.66%36.85%38.35%37.64%37.4%
Gross Profit Growth %-12.09%8.31%-2.93%0.95%-7.86%-21.93%-3.54%-11.34%-8.69%-8.72%-2.26%11.84%12.12%14.92%9.78%4.3%9.26%15.72%16.58%47.27%
Operating Expenses159.42M187.63M204.99M256.93M243.06M451.93M231.62M202.06M218.87M231.16M210.34M234.03M209.76M235.07M219.25M169.31M188.04M174.31M181.43M204.47M
OpEx % of Revenue16.01%18.87%20.4%24.89%24.7%45.08%22.94%19.69%21.64%22.81%20.49%22.08%20.38%21.37%22.17%17.4%20.57%19.26%20.25%22.36%
Selling, General & Admin159.42M187.63M177.59M191.55M177.8M195.71M199.21M169.79M186.29M197.14M176.11M199.76M174.85M199.64M183.71M131.71M150.03M144.11M148.57M171.5M
SG&A % of Revenue16.01%18.87%17.67%18.56%18.07%19.52%19.73%16.55%18.42%19.45%17.15%18.85%16.99%18.15%18.57%13.53%16.42%15.92%16.58%18.75%
Research & Development00000000000000000000
R&D % of Revenue--------------------
Other Operating Expenses001000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income119.9M120.22M133.8M100.13M74.67M-167.69M117.41M151.65M125.98M132.92M151.5M164.94M167.89M163.81M150.98M187.41M148.78M172.81M155.8M137.55M
Operating Margin %12.04%12.09%13.32%9.7%7.59%-16.73%11.63%14.78%12.45%13.12%14.76%15.56%16.31%14.89%15.26%19.26%16.28%19.09%17.39%15.04%
Operating Income Growth %60.57%171.69%13.96%-33.97%-40.73%-226.15%-22.51%-8.06%-24.97%-18.86%0.35%-11.99%12.85%-5.21%-3.1%36.25%20.27%34.03%17.36%79.18%
EBITDA187.05M198.5M218.96M219.64M195.03M-65.58M205.6M237.73M211.33M213.44M230.37M242.62M244.96M241.35M225.58M263.83M224.08M240.05M224.49M205.66M
EBITDA Margin %18.78%19.96%21.79%21.28%19.82%-6.54%20.36%23.17%20.89%21.06%22.44%22.89%23.8%21.94%22.81%27.11%24.52%26.52%25.06%22.49%
EBITDA Growth %-4.09%402.67%6.5%-7.61%-7.71%-130.73%-10.75%-2.01%-13.73%-11.57%2.12%-8.04%9.32%0.54%0.49%28.29%20.98%26.47%16.72%53.5%
D&A (Non-Cash Add-back)67.15M78.28M85.16M119.51M120.36M102.1M88.2M86.08M85.36M80.51M78.87M77.67M77.07M77.55M74.61M76.42M75.3M67.24M68.69M68.11M
EBIT119.9M120.22M112.6M101.39M63.86M-188.56M121.53M152.42M134.01M242.25M146.62M163.71M165.42M279.7M134.48M147.82M120.28M175.19M139.72M143.69M
Net Interest Income-25.71M-22.76M-23.98M-28.87M-26.48M-26.4M-28.76M-29.76M-32.8M-31.95M-32.37M-33.62M-33.57M-34.44M-11.25M-3.52M-9.31M-11.24M-16.32M-16.02M
Interest Income1.03M1.02M1.42M1.1M1.4M1.83M1.53M3.01M2.2M1.59M1.37M1.43M806K343K122K188K127K309K137K171K
Interest Expense26.74M23.77M25.4M29.97M27.88M28.23M30.28M32.77M35M33.54M33.74M35.04M34.38M34.78M11.38M3.7M9.43M11.55M16.45M16.19M
Other Income/Expense-149.84M-414.32M-46.6M-28.72M-38.69M-49.1M-26.16M-32M-26.97M75.78M-38.63M-36.28M-36.85M81.11M-27.87M-43.3M-37.93M-9.16M-32.53M-10.05M
Pretax Income-29.94M-294.1M87.2M71.42M35.98M-216.79M91.24M119.65M99.01M208.71M112.87M128.66M131.04M244.92M123.11M144.11M110.85M163.64M123.27M127.5M
Pretax Margin %-3.01%-29.58%8.68%6.92%3.66%-21.62%9.04%11.66%9.79%20.59%10.99%12.14%12.73%22.27%12.45%14.81%12.13%18.08%13.76%13.94%
Income Tax-15.14M-17.81M31.64M18.73M10.1M-3.04M20.95M25.39M24.53M19.75M24.85M29.22M27.09M55.81M25.5M33.45M15.62M23.82M18.11M37.58M
Effective Tax Rate %50.56%6.06%36.29%26.22%28.07%1.4%22.96%21.22%24.77%9.46%22.02%22.71%20.67%22.79%20.71%23.21%14.09%14.55%14.69%29.48%
Net Income-14.84M-276.56M54.42M52.33M25.47M-215.7M68.68M89.99M67.33M187.08M87.39M97.02M103.13M187.41M96.47M109.32M93.02M137.58M103.43M88.45M
Net Margin %-1.49%-27.82%5.42%5.07%2.59%-21.52%6.8%8.77%6.66%18.46%8.51%9.15%10.02%17.04%9.75%11.23%10.18%15.2%11.54%9.67%
Net Income Growth %-158.28%-28.21%-20.76%-41.85%-62.17%-215.3%-21.41%-7.25%-34.72%-0.17%-9.42%-11.25%10.87%36.22%-6.72%23.6%51.18%-3.92%0.5%31.16%
Net Income (Continuing)-14.84M-276.29M55.56M52.69M25.88M-213.75M70.3M94.26M74.48M188.95M88.02M99.44M103.95M189.11M97.61M110.66M95.23M139.83M105.16M89.92M
Discontinued Operations00000000000000000000
Minority Interest47.72M46.56M45.37M46.27M47.45M46.58M45.44M50.37M63.49M62.12M44.72M48.3M48.22M47.21M45.09M45.4M60.54M57.17M38.05M35.64M
EPS (Diluted)-0.30-5.621.101.060.50-4.221.331.741.303.621.691.892.013.651.882.131.812.672.011.72
EPS Growth %-160%-33.18%-17.29%-39.08%-61.54%-216.57%-21.3%-7.94%-35.32%-0.82%-10.11%-11.27%11.05%36.7%-6.47%23.84%50.83%-4.98%-0.99%28.36%
EPS (Basic)-0.30-5.621.111.060.50-4.221.341.751.313.651.701.892.013.681.902.151.842.732.051.76
Diluted Shares Outstanding48.95M49.22M49.43M49.32M50.85M51.14M51.58M51.85M51.84M51.62M51.61M51.47M51.43M51.38M51.28M51.28M51.33M51.55M51.56M51.33M
Basic Shares Outstanding48.95M49.22M49.21M49.15M50.68M51.14M51.39M51.55M51.44M51.31M51.28M51.22M51.31M50.91M50.87M50.82M50.64M50.47M50.42M50.3M
Dividend Payout Ratio--------------------